TickerFactsScreenerDevelopers

Skye Bioscience, Inc. (SKYE) — Capital Expenditures

Annual figures by fiscal year, from SEC filings.

2013: $49.1K2014: $23.3K2015: $2.0K2016: $11.1K2017: $19.7K2018: $4.4K2020: $7.2K2021: $90.9K2022: $28.1K2023: $12.6K2024: $1.60M2025: $6.3K$6.3K
2013Capital Expenditures (USD)2025
Fiscal YearCapital ExpendituresChange YoY
2025$6.3K-99.6%
2024$1.60M+12681.1%
2023$12.6K-55.3%
2022$28.1K-69.1%
2021$90.9K+1156.8%
2020$7.2K—
2018$4.4K-77.7%
2017$19.7K+76.8%
2016$11.1K+460.9%
2015$2.0K-91.5%
2014$23.3K-52.6%
2013$49.1K—